$60,000 of UNIVERSAL TECHNICAL INSTITUTE lobbying was just disclosed, from Q4 of 2025, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"Advocate on issues related to higher education"
You can find more data on corporate lobbying on Quiver Quantitative.
UTI Insider Trading Activity
UTI insiders have traded $UTI stock on the open market 8 times in the past 6 months. Of those trades, 8 have been purchases and 0 have been sales.
Here’s a breakdown of recent trading of $UTI stock by insiders over the last 6 months:
- CAPITAL MANAGEMENT, LLC COLISEUM has made 6 purchases buying 1,255,173 shares for an estimated $30,813,450 and 0 sales.
- ROBERT THOMAS DEVINCENZI has made 2 purchases buying 10,000 shares for an estimated $253,990 and 0 sales.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
UTI Hedge Fund Activity
We have seen 124 institutional investors add shares of UTI stock to their portfolio, and 141 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- FMR LLC removed 1,052,250 shares (-77.3%) from their portfolio in Q3 2025, for an estimated $34,250,737
- LORD, ABBETT & CO. LLC removed 948,967 shares (-46.7%) from their portfolio in Q3 2025, for an estimated $30,888,875
- PRICE T ROWE ASSOCIATES INC /MD/ added 931,489 shares (+2519.2%) to their portfolio in Q3 2025, for an estimated $30,319,966
- PERRITT CAPITAL MANAGEMENT INC removed 902,386 shares (-97.2%) from their portfolio in Q3 2025, for an estimated $29,372,664
- THRIVENT FINANCIAL FOR LUTHERANS added 857,889 shares (+inf%) to their portfolio in Q3 2025, for an estimated $27,924,286
- ROCKEFELLER CAPITAL MANAGEMENT L.P. added 736,168 shares (+inf%) to their portfolio in Q3 2025, for an estimated $23,962,268
- BLACKROCK, INC. added 719,979 shares (+22.0%) to their portfolio in Q3 2025, for an estimated $23,435,316
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
UTI Analyst Ratings
Wall Street analysts have issued reports on $UTI in the last several months. We have seen 2 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Barrington Research issued a "Outperform" rating on 01/21/2026
- Rosenblatt issued a "Buy" rating on 11/20/2025
To track analyst ratings and price targets for UTI, check out Quiver Quantitative's $UTI forecast page.
UTI Price Targets
Multiple analysts have issued price targets for $UTI recently. We have seen 2 analysts offer price targets for $UTI in the last 6 months, with a median target of $36.0.
Here are some recent targets:
- Alexander Paris from Barrington Research set a target price of $36.0 on 01/21/2026
- Steve Frankel from Rosenblatt set a target price of $36.0 on 11/20/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
